Evidence Report/Technology Assessment Number 77

Management of Treatment-Resistant Epilepsy
Volume 1. Evidence Report and Appendices
Volume 2. Evidence Tables

File Inventory

Prepared by:

ECRI, Plymouth Meeting, PA
Health Technology Assessment Group

Investigators
   Richard Chapell, Ph.D.
   James Reston, Ph.D.
   David Snyder, Ph.D.
   Jonathan Treadwell, Ph.D.
   Stephen Tregear, Ph.D.
   Charles Turkelson, Ph.D

File Name	Description			Software	Version	File	Size
________________________________________________________________________________________________
01v1frnt.doc	Microsoft Word® Document	MS Word®	2002	184KB	6 pages
Contents: Title Page, Preface, Structured Abstract
________________________________________________________________________________________________
02v1cnts.doc	Microsoft Word® Document	MS Word®	2002	350KB	7 pages
Contents: Table of Contents for Volume 1
________________________________________________________________________________________________
03v1summ.doc	Microsoft Word® Document	MS Word®	2002	92KB	13 pages
Contents: Summary: Overview, Reporting the Evidence, Methodology, Findings, Future Research
________________________________________________________________________________________________
04v1ch1.doc	Microsoft Word® Document	MS Word®	2002	532KB	7 pages
Contents: Chapter 1. Introduction: Scope and Objectives of this Report, Epilepsy and 
Treatment-Resistant Epilepsy, Technologies Assessed in this Report
________________________________________________________________________________________________
05v1ch2.doc	Microsoft Word® Document	MS Word®	2002	614KB	21 pages
Contents: Chapter 2. Methodology: Defining Treatment-Resistant Epilepsy, Expert Panel, 
Technical Experts, Key Questions, Causal Pathway, Literature Searches, Article Inclusion 
Criteria, Articles Identified, Statistical Methods, Methods of Evaluating Literature Quality, 
Presentation of Results, Peer Review
________________________________________________________________________________________________
06v1ch3.doc	Microsoft Word® Document	MS Word®	2002	2.8MB	211 pages
Contents: Chapter 3. Results: Definitions of Treatment-Resistant Epilepsy, Rediagnosing and 
Reevaluating Treatment-Resistant Epilepsy, Optimization of Antiepileptic Drugs, Drug Treatment 
Strategies, Nondrug Treatments, Nonmedical Treatments, Employment and School, Mortality Rate, 
Frequency and Type of Seizure and Sudden Death
________________________________________________________________________________________________
07v1ch4.doc	Microsoft Word® Document	MS Word®	2002	537KB	12 pages
Contents: Chapter 4. Conclusions: Definition of Treatment-Resistant Epilepsy, Rediagnosing 
and Re-evaluating Treatment-Resistant Epilepsy, Optimization of Antiepileptic Drugs, 
Drug Treatment Strategies, Surgical Interventions, Nondrug, Nonsurgical Treatments, 
Nonmedical Treatments, Employment and School, Mortality Rate, Frequency and Type of Seizure 
and Sudden Death
________________________________________________________________________________________________
08v1ch5.doc	Microsoft Word® Document	MS Word®	2002	496KB	3 pages
Contents: Chapter 5. Future Research: Shortcomings of Available Research, Optimal Study Designs
________________________________________________________________________________________________
09v1refs.doc	Microsoft Word® Document	MS Word®	2002	591KB	15 pages
Contents: References
________________________________________________________________________________________________
10v1appa.doc	Microsoft Word® Document	MS Word®	2002	507KB	6 pages
Contents: Appendix A. Search Strategies
________________________________________________________________________________________________
11v1appb.doc	Microsoft Word® Document	MS Word®	2002	789KB	23 pages
Contents: Appendix B. Internal Validity
________________________________________________________________________________________________
12v2frnt.doc	Microsoft Word® Document	MS Word®	2002	174KB	2 pages
Contents: Title Page for Volume 2 (Evidence Tables)
________________________________________________________________________________________________
13v2cnts.doc	Microsoft Word® Document	MS Word®	2002	384KB	10 pages
Contents: Table of Contents for Volume 2
________________________________________________________________________________________________
14v2abbr.doc	Microsoft Word® Document	MS Word®	2002	26KB	1 page
Contents: Abbreviations used in the Evidence Tables
________________________________________________________________________________________________
15v2et-a.doc	Microsoft Word® Document	MS Word®	2002	8.3MB	252 pages
Contents: Questions 1 through 4, Evidence Tables 1 through 101 
(see list of Table titles in file 13v2cnts.doc)
________________________________________________________________________________________________
16v2et-b.doc	Microsoft Word® Document	MS Word®	2002	5.8MB	212 pages
Contents: Questions 5 through 9, Evidence Tables 102 through 255
(see list of Table titles in file 13v2cnts.doc)
________________________________________________________________________________________________
17v2bib.doc	Microsoft Word® Document	MS Word®	2002	316KB	21 pages
Contents: Bibliography
________________________________________________________________________________________________

AHRQ Publication No. 03-E028
Current as of May 2003

Internet Citation:

Management of Treatment-Resistant Epilepsy: Volume 1. Evidence Report and Appendices, Volume 2. Evidence Tables. File Inventory, Evidence Report/Technology Assessment Number 77. AHRQ Publication No. 03-E028, May 2003. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/trepiinv.htm.

Return to Evidence-based Practice
Clinical Information
AHRQ Home Page
Department of Health and Human Services